We measured the T1 MRI of HMEC, MCF-7 HER-2-positive, and MCF-7 (Neo-4) HER-2-negative breast cancer cell lines in both untreated and colchicine-treated cells after 1, 3, and 6 weeks. This evidence concerns the gene ERBB2 and breast cancer.